Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & DevfiledCriticalYeda Res & Dev
Priority to MYPI9001473priorityCriticalpatent/MY130049A/en
Publication of MY130049ApublicationCriticalpatent/MY130049A/en
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Abstract
A NOVEL OLIGODENDROCYTE CYTOTOXIC FACTOR, SALTS, PRECURSORS, FRAGMENTS AND HOMOLOGS THEREOF AND FUNCTIONAL DERIVATIVES OF SAID FACTOR OR OF ITS FRAGMENTS OR HOMOLOGS, ARE SELECTIVELY TOXIC TO THE OLIGODENDROCYTE LINEAGE. PHARMACEUTICAL COMPOSITIONS COMPRISING THEM ARE USEFUL FOR INDUCING REGENERATION OF INJURED NERVES OF THE CENTRAL NERVOUS SYSTEM IN MAMMALS.
The use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura